Results 101 to 110 of about 76,424 (294)

Metabool syndroom bij de behandeling met clozapine [PDF]

open access: yes, 2009
Metabolic syndrome during clozapine treatment Objective: To assess the prevalence of metabolic syndrome in inpatients with psychotic disorders treated with clozapine for at least one year.
Heijden, F.M.M.A. (Frank) van der   +5 more
core   +1 more source

Bitopic binding mode of an M1 muscarinic acetylcholine receptor agonist associated with adverse clinical trial outcomes [PDF]

open access: yes, 2018
The realisation of the therapeutic potential of targeting the M1 muscarinic acetylcholine receptor (M1 mAChR) for the treatment of cognitive decline in Alzheimer's disease has prompted the discovery of M1 mAChR ligands showing efficacy in alleviating ...
Bradley, Sophie J.   +14 more
core   +1 more source

Evaluation of preclinical antipsychotic models used to support first‐in‐human clinical trials

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Schizophrenia is regarded as a complex and heterogeneous psychiatric disorder, characterised by diverse symptoms and comorbidities, which complicate both clinical management and drug development. Current pharmacological treatment, primarily based on dopamine D2 receptor antagonism or partial agonism, which has not markedly progressed since the
Thi Viet Ha Nguyen   +2 more
wiley   +1 more source

Clozapine-induced myocarditis: a case report and literature review [PDF]

open access: gold, 2022
I. Angélico Ferreira   +4 more
openalex   +1 more source

GPi‐DBS for SERAC1‐Related Dystonia‐Parkinsonism

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Vidal Yahya   +13 more
wiley   +1 more source

Clinical Evaluation of a Novel Point‐of‐Care Hematology Analyzer for Complete Blood Count With Differential

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction Point‐of‐care testing (POCT) for hematology enables clinicians to access actionable results during patient visits, supporting timely decisions such as transfusions or chemotherapy adjustments. However, POCT analyzers must demonstrate clinical performance comparable to centralized laboratory systems. We conducted a proof‐of‐concept
Ryan C. Shean, Sterling T. Bennett
wiley   +1 more source

Annual Research Review: Psychosis in children and adolescents: key updates from the past 2 decades on psychotic disorders, psychotic experiences, and psychosis risk

open access: yesJournal of Child Psychology and Psychiatry, Volume 66, Issue 4, Page 460-476, April 2025.
Psychosis in children and adolescents has been studied on a spectrum from (common) psychotic experiences to (rare) early‐onset schizophrenia spectrum disorders. This research review looks at the state‐of‐the‐art for research across the psychosis spectrum, from evidence on psychotic experiences in community and clinical samples of children and ...
Ian Kelleher
wiley   +1 more source

Combination of clozapine with an atypical antipsychotic: a meta-analysis [PDF]

open access: yes, 2017
Purpose The purpose of this paper is to review the efficacy of atypical antipsychotics in combination with clozapine. Previous meta-analyses have assessed the use of both typical and atypical antipsychotics in combination with clozapine, combination ...
McGarry, Kenneth, Rolph, Lauren
core   +1 more source

Annual Research Review: Psychosis in children and adolescents – a call to action: a commentary on Kelleher (2025)

open access: yesJournal of Child Psychology and Psychiatry, Volume 66, Issue 4, Page 588-591, April 2025.
The spectrum of psychosis is highly relevant to child and adolescent mental health. Psychotic symptoms are common in children and adolescents. The onset of psychotic disorders is often preceded by neurodevelopmental problems in early childhood, and some 13% of adolescents attending specialist mental health services will later be diagnosed with a ...
James G. Scott
wiley   +1 more source

Sudden Cardiac Death with Clozapine and Lorazepam Combination [PDF]

open access: yes, 2012
Objective: To report a case of sudden cardiac death in a patient taking a combination of clozapine and lorazepam. Case summary: A 31-year-old white man with schizophrenia was found dead at his apartment.
Bhatia, Subhash C.   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy